Analysis of recombinant adenoviruses using an integrated microfluidic chip-based system

Area of Science:

• Biotechnology
• Molecular Biology
• Gene Therapy

Background:

• Rigorous quality control is essential for recombinant viral vectors used in gene therapy to ensure safety and functionality.
• Current viral identity testing involves PCR amplification and restriction enzyme digestion, with DNA fragment analysis typically performed using agarose gel electrophoresis.

Purpose of the Study:

• To investigate the utility of an integrated microfluidic chip-based system for quality control testing of recombinant adenoviral gene therapy products.
• To compare the performance of the microfluidic chip system against traditional agarose gel electrophoresis for viral DNA fragment analysis.

Main Methods:

• Utilized a microfluidic chip-based system for the analysis of DNA fragments generated from PCR-amplified viral payloads.
• Performed restriction enzyme digestion to create characteristic DNA fingerprints.
• Compared the sensitivity, speed, and data analysis capabilities of the chip-based system with agarose gel electrophoresis.

Main Results:

• The microfluidic chip system demonstrated high sensitivity, requiring 100-fold less sample than agarose gel electrophoresis.
• The chip-based method was significantly faster, completing analysis in one-third the time of the traditional method.
• Automated data analysis provided more thorough, reproducible, and sensitive sizing and quantitation of DNA fragments.

Conclusions:

• The integrated microfluidic chip system represents a significant advancement in the quality control of gene therapy viral vectors.
• This technology offers a more efficient, sensitive, and reproducible alternative to conventional agarose gel electrophoresis for viral identity testing.
• The system enhances the overall quality control process for recombinant adenoviral gene therapy products.